Ibrutinib and Idelalisib For CLL

The mechanisms of ibrutinib and idelalisib for the treatment of chronic lymphocytic leukemia (CLL). Thomas Kipps, MD, PhD, Division of Hematology-Oncology Deputy Director for Research at the UC San D... Author: onclivetv Added: 03/06/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts